Annals of Epidemiology
Volume 19, Issue 12 , Pages 841-849, December 2009

Anthropometric Correlates of Insulin-Like Growth Factor 1 (IGF-1) and IGF Binding Protein-3 (IGFBP-3) Levels by Race/Ethnicity and Gender

  • Jessica M. Faupel-Badger

      Affiliations

    • Cancer Prevention Fellowship Program, National Cancer Institute, National Institutes of Health, Bethesda, MD
    • Corresponding Author InformationAddress correspondence to: Jessica M. Faupel-Badger, National Institutes of Health, 6120 Executive Blvd. (EPS), Suite 150E, MSC 7105, Bethesda, MD 20892. Tel: (301) 496-8640. Fax: (301) 480-2669.
  • ,
  • David Berrigan

      Affiliations

    • Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD
  • ,
  • Rachel Ballard-Barbash

      Affiliations

    • Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD
  • ,
  • Nancy Potischman

      Affiliations

    • Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD

Received 29 January 2009; accepted 12 August 2009.

Purpose

Insulin-like growth factor 1 (IGF-1) levels are positively related to some cancers and negatively related to cardiovascular disease. These conditions are also related to insulin resistance and high body weight, leading to the hypothesis that IGF-1 levels may, in part, mediate the association of high body weight with these health outcomes. Using the National Health and Nutrition Examination Survey (NHANES) III population, we examined the associations between IGF-1, IGF binding protein-3 (IGFBP-3), and the IGF-1/IGFBP-3 molar ratio with anthropometric measures in a large, U.S. population-based study where these associations could also be stratified by race/ethnicity and gender.

Methods

The study population consisted of 3,168 women and 2,635 men (44% non-Hispanic white, 28.2% non-Hispanic black, and 27.7% Mexican-American). Anthropometric measures were obtained by trained personnel in the NHANES mobile examination centers. IGF-1 and IGFBP-3 were measured using immunoassays by staff at Diagnostic System Laboratories (DSL) Inc. (Webster, TX). Associations of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio with anthropometric variables across race/ethnicity and gender were evaluated by using linear regression modeling.

Results

Body mass index (BMI) was inversely associated with IGF-1 levels across all of the race/ethnicity and gender subgroups. In contrast, BMI, waist to hip ratio (WHR), and waist circumference were positively associated with IGFBP-3 levels only in non-Hispanic black men and non-Hispanic white women. The IGF-1/IGFBP-3 molar ratio was inversely associated with all anthropometric measures, except height, in all subgroups of the population.

Conclusion

The significant inverse associations of BMI with IGF-1 levels and of all anthropometric variables, except height, with the IGF-1:IGFBP-3 molar ratio in all subgroups do not support existing hypotheses that associations of excess weight with negative health outcomes, such as specific cancer diagnoses, are mediated through high IGF-1 levels.

Key Words: BMI, Obesity, Cancer, IGF

Selected Abbreviations and Acronyms: BMI, body mass index, IGF-1, insulin-like growth factor 1, IGFBP-3, insulin-like growth factor binding protein 3, NH, Non-Hispanic, NHANES, National Health and Nutrition Examination Survey, WHR, waist to hip ratio

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1047-2797(09)00301-9

doi:10.1016/j.annepidem.2009.08.005

Annals of Epidemiology
Volume 19, Issue 12 , Pages 841-849, December 2009